AFC-HD AMS Life Science Co., Ltd. (TYO:2927)

AFC-HD AMS Life Science Revenue

AFC-HD AMS Life Science had revenue of 8.30B JPY in the quarter ending February 28, 2026, a decrease of -1.50%. This brings the company's revenue in the last twelve months to 32.89B, up 1.95% year-over-year. In the fiscal year ending August 31, 2025, AFC-HD AMS Life Science had annual revenue of 32.66B with 8.18% growth.

• Revenue (ttm): 32.89B
• Revenue Growth: +1.95%
• P/S Ratio: 0.38
• Revenue / Employee: 32.63M
• Employees: 1,008
• Market Cap: 12.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2025	32.66B	2.47B	8.18%
Aug 31, 2024	30.19B	4.61B	18.01%
Aug 31, 2023	25.58B	2.58B	11.23%
Aug 31, 2022	23.00B	629.00M	2.81%
Aug 31, 2021	22.37B	6.55B	41.40%